Associations of polymorphisms in the apolipoprotein A1/C3/A4/A5 gene cluster with familial combined hyperlipidaemia in Hong Kong Chinese.

BACKGROUND Familial combined hyperlipidaemia (FCH) is the most common genetic dyslipidaemia associated with coronary artery disease. Single nucleotide polymorphisms (SNPs) and haplotypes in the APOA1/C3/A4/A5 gene cluster are associated with FCH in Caucasians and with elevated triglycerides (TG) in various ethnic groups. We examined these associations with FCH in Hong Kong Chinese. METHODS Fifty-six Chinese FCH patients and 176 unrelated controls were studied. Thirteen SNPs in the APOA1/C3/A4/A5 cluster were genotyped. RESULTS Four alleles in APOA5 were associated with FCH (P<0.001). The -1131T>C (rs662799) and -3A>G (rs651821) SNPs in APOA5 were in almost complete linkage disequilibrium (LD, r(2)=0.99), and their minor alleles were more frequent (P<0.001) in FCH than controls (0.60 vs. 0.24). The odds ratio (OR) for FCH was 6.2 (95% CI, 2.6-14.8) and 6.1 (2.6-14.6) per copy of -1131C and -3G, respectively, and 24.6 (8.4-72.0) and 24.4 (8.4-70.9) in -1131C and -3G homozygotes, respectively, as compared to wild-type homozygotes. The 1891T>C (rs2266788) SNP was in LD (r(2)=0.68) with -1131T>C and -3A>G, and the minor allele was more frequent in FCH than controls (0.42 vs. 0.19, P<0.001). The 553G>T (rs2075291) nonsynonymous variant was also associated with FCH (0.15 vs. 0.04, P=0.001) and, along with -3A>G (or -1131T>C) and 1891T>C, contributed to haplotypes predicting FCH. The two tightly linked SNPs, -1131T>C and -3A>G polymorphism were significantly associated with lipid traits in all subjects combined, with variant homozygous subjects having higher TG and LDL-C and lower HDL-C levels. CONCLUSIONS Some common polymorphisms and haplotypes in APOA5 are closely associated with FCH in Hong Kong Chinese, and these differ from those found in Caucasians.

[1]  Mario Falchi,et al.  Genome-wide Association Study Identifies Genes for Biomarkers of Cardiovascular Disease: Serum Urate and Dyslipidemia , 2022 .

[2]  J. Ribalta,et al.  Newly identified apolipoprotein AV gene predisposes to high plasma triglycerides in familial combined hyperlipidemia. , 2002, Clinical chemistry.

[3]  L. Hsu,et al.  Genetic variations of apolipoprotein A5 gene is associated with the risk of coronary artery disease among Chinese in Taiwan. , 2006, Atherosclerosis.

[4]  H. Yoshida,et al.  Prediction of genetic risk for metabolic syndrome. , 2007, Atherosclerosis.

[5]  P. Talmud,et al.  Haplotype analyses of the APOA5 gene in patients with familial combined hyperlipidemia. , 2007, Biochimica et biophysica acta.

[6]  Swneke D. Bailey,et al.  Familial combined hyperlipidaemia: how can genetic disorders be common, complex and comprehensible? , 2007, Clinical science.

[7]  B. Melegh,et al.  Apolipoprotein A5 T-1131C variant confers risk for metabolic syndrome , 2008, Pathology & Oncology Research.

[8]  S. Yusuf,et al.  APOA5 genetic variants are markers for classic hyperlipoproteinemia phenotypes and hypertriglyceridemia , 2008, Nature Clinical Practice Cardiovascular Medicine.

[9]  D. Corella,et al.  APOA5 gene variation modulates the effects of dietary fat intake on body mass index and obesity risk in the Framingham Heart Study , 2007, Journal of Molecular Medicine.

[10]  A. Motulsky,et al.  Small, Dense LDL and Elevated Apolipoprotein B Are the Common Characteristics for the Three Major Lipid Phenotypes of Familial Combined Hyperlipidemia , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[11]  E. Tai,et al.  Clinical significance of apolipoprotein A5 , 2008, Current opinion in lipidology.

[12]  Marcia M. Nizzari,et al.  Genome-Wide Association Analysis Identifies Loci for Type 2 Diabetes and Triglyceride Levels , 2007, Science.

[13]  A. Kondacs,et al.  Apolipoprotein A5 gene promoter region T-1131C polymorphism associates with elevated circulating triglyceride levels and confers susceptibility for development of ischemic stroke , 2007, Journal of Molecular Neuroscience.

[14]  P. Talmud,et al.  The functional interaction on in vitro gene expression of APOA5 SNPs, defining haplotype APOA52, and their paradoxical association with plasma triglyceride but not plasma apoAV levels. , 2008, Biochimica et biophysica acta.

[15]  P. Talmud,et al.  Apolipoprotein A-V, triglycerides and risk of coronary artery disease: the prospective Epic-Norfolk Population Study Published, JLR Papers in Press, June 12, 2006. , 2006, Journal of Lipid Research.

[16]  J. Fruchart,et al.  Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome , 2007, Clinical chemistry and laboratory medicine.

[17]  Le-ming Fan,et al.  A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. , 2006, Atherosclerosis.

[18]  K. Chien,et al.  APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[19]  Zhi-nong Yin,et al.  A single nucleotide polymorphism -1131T>C in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and alters triglyceride metabolism in Chinese. , 2004, Molecular genetics and metabolism.

[20]  J. Pankow,et al.  Coronary Artery Disease Risk in Familial Combined Hyperlipidemia and Familial Hypertriglyceridemia: A Case-Control Comparison From the National Heart, Lung, and Blood Institute Family Heart Study , 2003, Circulation.

[21]  T. D. de Bruin,et al.  Excess coronary heart disease in Familial Combined Hyperlipidemia, in relation to genetic factors and central obesity. , 2001, Atherosclerosis.

[22]  C. V. D. van der Kallen,et al.  Five-year follow-up of waist circumference, insulin and ALT levels in familial combined hyperlipidaemia. , 2007, Clinical science.

[23]  Jonathan C. Cohen,et al.  An Apolipoprotein Influencing Triglycerides in Humans and Mice Revealed by Comparative Sequencing , 2001, Science.

[24]  G. Jarvik,et al.  Frequent detection of familial hypercholesterolemia mutations in familial combined hyperlipidemia. , 2008, Journal of the American College of Cardiology.

[25]  Sheng-kai Yan,et al.  Apolipoprotein A5 gene polymorphism –1131T→C: association with plasma lipids and type 2 diabetes mellitus with coronary heart disease in Chinese , 2005, Clinical chemistry and laboratory medicine.

[26]  M. Rieder,et al.  Genetic Loci Associated With Plasma Concentration of Low-Density Lipoprotein Cholesterol, High-Density Lipoprotein Cholesterol, Triglycerides, Apolipoprotein A1, and Apolipoprotein B Among 6382 White Women in Genome-Wide Analysis With Replication , 2008, Circulation. Cardiovascular genetics.

[27]  D. Nebert,et al.  Association between DNA variant sites in the apolipoprotein A5 gene and coronary heart disease in Chinese. , 2005, Metabolism: clinical and experimental.

[28]  F. Kronenberg,et al.  APOA5 variants and metabolic syndrome in Caucasianss⃞s⃞ The online version of this article (available at http://www.jlr.org) contains supplementary data in the form of three tables, one figure. Published, JLR Papers in Press, September 3, 2007. , 2007, Journal of Lipid Research.

[29]  J. Hendriks,et al.  Nomogram to Diagnose Familial Combined Hyperlipidemia on the Basis of Results of a 5-Year Follow-Up Study , 2004, Circulation.

[30]  Päivi Pajukanta,et al.  Association of the APOLIPOPROTEIN A1/C3/A4/A5 Gene Cluster With Triglyceride Levels and LDL Particle Size in Familial Combined Hyperlipidemia , 2004, Circulation research.

[31]  B. Tomlinson,et al.  APOA5‐1131T>C polymorphism is associated with triglyceride levels in Chinese men , 2003, Clinical genetics.

[32]  E. Ros,et al.  Frequency of low-density lipoprotein receptor gene mutations in patients with a clinical diagnosis of familial combined hyperlipidemia in a clinical setting. , 2008, Journal of the American College of Cardiology.

[33]  Hetal N. Patel,et al.  Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[34]  Y. Yamada,et al.  Genetic risk for metabolic syndrome: examination of candidate gene polymorphisms related to lipid metabolism in Japanese people , 2007, Journal of Medical Genetics.